At Ki Health Partners we believe the ‘ki’ to success is focusing on the client, the science, and the patient.
As a Contract Research Organization our goal is work hand-in-glove with the sponsor to ensure the success of their clinical trial by providing best in class services in a timely, ethical and cost-effective manner. More than a typical CRO, Ki Clinical Research functions as a Rapid Research Organization (RRO), combining the power of next generation AI with human wisdom to provide a integrated, modern approach to clinical trial execution.
As a Site Management Organization, we work tirelessly with research-minded medical practices to get them the right studies and infrastructure to ensure success, while removing the hassles such as regulatory, HR and budget negotiations, so they can focus on the science.
Our medical practice consulting unit seeks to provide clinicians who are thinking about starting a non-insurance-based model the tools to hit the ground running. Finally, our clinical research unit strives to deliver high-quality data through aggressive subject recruitment, enrollment and retention.
Angelo is Chief Executive Officer and President of KHP (Ki Health Partners) LLC, and with the New England Institute for Clinical Research and New England Institute for Neurology and Headache. Angelo started his career in research at Yale University, School of Medicine, Department of Psychiatry in New Haven. He then transitioned to Research Manager at a large neurology practice in Fairfield, where he participated in more than 100 studies, and sucessfully lead a team of clinical research coordinators for more than eight years before the launch of Ki Health Partners, LLC. In addition to holding master’s degrees in science management and business administration, Angelo is certified as a Clinical Research Associate, Clinical Research Coordinator, and Clinical Research Contract Professional. He is a certified rater with extensive experience on the following scales: NIH Stroke Scale, ADAS-Cog, NPI, MMSE and multiple clinical psychiatric assessment certifications. He is a member of MAGI (Models Agreements and Guidelines International) as well as the Headache Cooperative of New England, has lectured extensively on clinical research throughout the country, and has coauthored numerous scientific papers.
Peter is Chief Medical Officer and Cofounder of KHP (Ki Health Partners). He is a board-certified neurologist with over 25 years’ experience working with pharmaceutical, biotech and device companies in all aspects of clinical research, from trial design to execution to data analysis and publication. He has been a principle investigator on over 350 phase 1-4 studies, and has published more than 150 articles, scientific posters, abstracts and book chapters.
At Ki Clinical Research we are committed to:
Our light bulb moment came a few years back. Our Site Management Organization was trying to get the (large, mullti-national, very well known) CRO to adopt some novel recruitment strategies for a study that was beginning to lag. They refused. We pushed. Crickets. Finally we asked to escalate the issue to the sponsor, and we were told, “You can’t talk to the sponsor”.
It was then and there that we said, “We can do better”.
At Ki Clinical Research we think a Contract Research Organization should facilitate a strong working relationship between the two most interested parties: the sponsor and the sites. But increasingly we’ve see the rise of multi-billion dollar CROs who feel that it’s all about them. Full of arbitrary rules and many mouths to feed, these conglomerates seem to have a “too big to fail” mentality.
We’re different. We’re small by design. We’re detail-obsessed but built for speed. We understand exactly what sponsors want, and we can deliver an outstanding service rapidly, responsibly, honestly and cost-effectively.
We cut our teeth in Neurology P1-4 studies, but over the years we’ve added psychiatry, pain, medical devices, urology and cardiology. We’re up for more as the situation dictates. We believe out skill set transcends any one discipline.
While we’ve worked with all sizes and shapes of pharma and biotech, we feel Ki Clinical Research is best utilized by small-to-medium size companies, looking to run studies from early phase 2 through phase three and beyond.
Give as or call or contact us through the site. We look forward to working with you.